TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the “Company”), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on October 16, 2015 from the NYSE MKT LLC (the “Exchange”) indicating that the Company is below certain] []

By | 2016-03-19T14:04:58+00:00 October 19th, 2015|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:54:56+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] CORRESP: 787 Seventh Avenue New York, NY 10019-6099 Tel:

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:56:08+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:57:25+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ],

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:58:44+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 26,619,376 Item 6: 0 Item 7: 27,432,304 Item 8: 0 Item 9: 27,432,304 Item 11: 4.825% Item 12: FI Cusip #G98079109 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware]

By | 2016-03-24T01:59:55+00:00 October 2nd, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13G/A: Item 1: Reporting Person – FIL Limited Item

[Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 26,619,376 Item 6: 0 Item 7: 27,432,304 Item 8: 0 Item 9: 27,432,304 Item 11: 4.825% Item 12: FI Cusip #G98079109 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware]

By | 2016-03-24T02:02:07+00:00 October 2nd, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More
Skip to toolbar